You are here

  • Home
  • Archive
  • Volume 69, Issue 3
  • Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

Article info

Article menu
Clinical and epidemiological research
Extended report
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

Authors

  1. Correspondence to Professor D P M Symmons, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK; deborah.symmons{at}manchester.ac.uk
View Full Text

Citation

Dixon WG, Hyrich KL, Watson KD on behalf of the BSR Biologics Register, et al
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
Annals of the Rheumatic Diseases 2010;69:522-528.

Publication history

  • Accepted October 3, 2009
  • First published October 22, 2009.
Online issue publication 
November 02, 2019

Article Versions

  • Web Only Data ard.2009.118935

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl